327 related articles for article (PubMed ID: 35012401)
21. Facile synthesis and
Punia R; Mor S; Khatri M; Kumar D; Das PP; Jindal DK; Kumar A; Selvaraj P; Kumar R; Mohil R; Jakhar K
Future Med Chem; 2024; 16(10):999-1027. PubMed ID: 38910576
[TBL] [Abstract][Full Text] [Related]
22. Multitargeted inhibition of key enzymes associated with diabetes and Alzheimer's disease by 1,3,4-oxadiazole derivatives: Synthesis, in vitro screening, and computational studies.
Fatima B; Saleem F; Salar U; Chigurupati S; Felemban SG; Ul-Haq Z; Tariq SS; Almahmoud SA; Taha M; Shah STA; Khan KM
Arch Pharm (Weinheim); 2023 Dec; 356(12):e2300384. PubMed ID: 37806747
[TBL] [Abstract][Full Text] [Related]
23. Synthesis of new α-glucosidase inhibitors based on oleanolic acid incorporating cinnamic amides.
Nie W; Luo JG; Wang XB; Yin H; Sun HB; Yao HQ; Kong LY
Chem Pharm Bull (Tokyo); 2011; 59(8):1051-6. PubMed ID: 21804254
[TBL] [Abstract][Full Text] [Related]
24. Synthesis and Molecular Docking Studies of Alkoxy- and Imidazole-Substituted Xanthones as α-Amylase and α-Glucosidase Inhibitors.
Aguila-Muñoz DG; Vázquez-Lira G; Sarmiento-Tlale E; Cruz-López MC; Jiménez-Montejo FE; López Y López VE; Escalante CH; Andrade-Pavón D; Gómez-García O; Tamariz J; Mendieta-Moctezuma A
Molecules; 2023 May; 28(10):. PubMed ID: 37241920
[TBL] [Abstract][Full Text] [Related]
25. Utilization of the common functional groups in bioactive molecules: Exploring dual inhibitory potential and computational analysis of keto esters against α-glucosidase and carbonic anhydrase-II enzymes.
Khan I; Khan A; Halim SA; Khan M; Zaib S; Al-Yahyaei BEM; Al-Harrasi A; Ibrar A
Int J Biol Macromol; 2021 Jan; 167():233-244. PubMed ID: 33249154
[TBL] [Abstract][Full Text] [Related]
26. Isolated compounds from Dracaena angustifolia Roxb and acarbose synergistically/additively inhibit α-glucosidase and α-amylase: an in vitro study.
Yi J; Zhao T; Zhang Y; Tan Y; Han X; Tang Y; Chen G
BMC Complement Med Ther; 2022 Jul; 22(1):177. PubMed ID: 35780093
[TBL] [Abstract][Full Text] [Related]
27. Synthesis of Novel Benzimidazole-Based Thiazole Derivatives as Multipotent Inhibitors of α-Amylase and α-Glucosidase: In Vitro Evaluation along with Molecular Docking Study.
Hussain R; Iqbal S; Shah M; Rehman W; Khan S; Rasheed L; Rahim F; Dera AA; Kehili S; Elkaeed EB; Awwad NS; Bajaber MA; Alahmdi MI; Alrbyawi H; Alsaab HO
Molecules; 2022 Sep; 27(19):. PubMed ID: 36234994
[TBL] [Abstract][Full Text] [Related]
28. Synthesis, biological evaluation, and molecular modelling of novel quinoxaline-isoxazole hybrid as anti-hyperglycemic.
Phongphane L; Mohd Radzuan SN; Abu Bakar MH; Che Omar MT; Supratman U; Harneti D; A Wahab H; Azmi MN
Comput Biol Chem; 2023 Oct; 106():107938. PubMed ID: 37542847
[TBL] [Abstract][Full Text] [Related]
29. Synthesis and biological evaluation of novel oleanolic acid analogues as potential α-glucosidase inhibitors.
Zhong YY; Chen HS; Wu PP; Zhang BJ; Yang Y; Zhu QY; Zhang CG; Zhao SQ
Eur J Med Chem; 2019 Feb; 164():706-716. PubMed ID: 30677669
[TBL] [Abstract][Full Text] [Related]
30. Inhibition of α-glucosidase and α-amylase by diaryl derivatives of imidazole-thione and 1,2,4-triazole-thiol.
Balba M; El-Hady NA; Taha N; Rezki N; El Ashry el SH
Eur J Med Chem; 2011 Jun; 46(6):2596-601. PubMed ID: 21497424
[TBL] [Abstract][Full Text] [Related]
31. Novel C-2 Symmetric Molecules as α-Glucosidase and α-Amylase Inhibitors: Design, Synthesis, Kinetic Evaluation, Molecular Docking and Pharmacokinetics.
Shahzad D; Saeed A; Larik FA; Channar PA; Abbas Q; Alajmi MF; Arshad MI; Erben MF; Hassan M; Raza H; Seo SY; El-Seedi HR
Molecules; 2019 Apr; 24(8):. PubMed ID: 30999646
[TBL] [Abstract][Full Text] [Related]
32. Inhibition of α-glucosidase and α-amylase by herbal compounds for the treatment of type 2 diabetes: A validation of in silico reverse docking with in vitro enzyme assays.
Tolmie M; Bester MJ; Apostolides Z
J Diabetes; 2021 Oct; 13(10):779-791. PubMed ID: 33550683
[TBL] [Abstract][Full Text] [Related]
33. Exploring efficacy of indole-based dual inhibitors for α-glucosidase and α-amylase enzymes: In silico, biochemical and kinetic studies.
Kawde AN; Taha M; Alansari RS; Almandil NB; Anouar EH; Uddin N; Rahim F; Chigurupati S; Nawaz M; Hayat S; Ibrahim M; Elakurthy PK; Vijayan V; Morsy M; Ibrahim H; Baig N; Khan KM
Int J Biol Macromol; 2020 Jul; 154():217-232. PubMed ID: 32173438
[TBL] [Abstract][Full Text] [Related]
34. Design and synthesis of 2-amino-4,6-diarylpyrimidine derivatives as potent α-glucosidase and α-amylase inhibitors: structure-activity relationship,
Mughal EU; Amjid S; Sadiq A; Naeem N; Nazir Y; Alrafai HA; Hassan AA; Al-Nami SY; Abdel Hafez AA; Ali Shah SW; Ghias M
J Biomol Struct Dyn; 2024; 42(1):244-260. PubMed ID: 37096830
[TBL] [Abstract][Full Text] [Related]
35. Synthesis and in vitro evaluation of chlorogenic acid amides as potential hypoglycemic agents and their synergistic effect with acarbose.
Cardullo N; Floresta G; Rescifina A; Muccilli V; Tringali C
Bioorg Chem; 2021 Dec; 117():105458. PubMed ID: 34736132
[TBL] [Abstract][Full Text] [Related]
36. New quinoxalinone inhibitors targeting secreted phospholipase A2 and α-glucosidase.
Alasmary FAS; Alnahdi FS; Ben Bacha A; El-Araby AM; Moubayed N; Alafeefy AM; El-Araby ME
J Enzyme Inhib Med Chem; 2017 Dec; 32(1):1143-1151. PubMed ID: 28856929
[TBL] [Abstract][Full Text] [Related]
37. Synthesis of new indazole based dual inhibitors of α-glucosidase and α-amylase enzymes, their in vitro, in silico and kinetics studies.
Rafique R; Khan KM; Arshia ; Kanwal ; Chigurupati S; Wadood A; Rehman AU; Karunanidhi A; Hameed S; Taha M; Al-Rashida M
Bioorg Chem; 2020 Jan; 94():103195. PubMed ID: 31451297
[TBL] [Abstract][Full Text] [Related]
38. Synthesis, α-glucosidase and α-amylase inhibitory activities, acute toxicity and molecular docking studies of thiazolidine-2,4-diones derivatives.
Fettach S; Thari FZ; Hafidi Z; Tachallait H; Karrouchi K; El Achouri M; Cherrah Y; Sefrioui H; Bougrin K; Faouzi MEA
J Biomol Struct Dyn; 2022 Nov; 40(18):8340-8351. PubMed ID: 33847536
[TBL] [Abstract][Full Text] [Related]
39. Synthesis of indole derivatives as diabetics II inhibitors and enzymatic kinetics study of α-glucosidase and α-amylase along with their in-silico study.
Taha M; Alrashedy AS; Almandil NB; Iqbal N; Anouar EH; Nawaz M; Uddin N; Chigurupati S; Wadood A; Rahim F; Das S; Venugopal V; Nawaz F; Khan KM
Int J Biol Macromol; 2021 Nov; 190():301-318. PubMed ID: 34481854
[TBL] [Abstract][Full Text] [Related]
40. Benzimidazole Bearing Thiosemicarbazone Derivatives Act as Potent α-Amylase and α-Glucosidase Inhibitors; Synthesis, Bioactivity Screening and Molecular Docking Study.
Ullah H; Khan S; Rahim F; Taha M; Iqbal R; Sarfraz M; Shah SAA; Sajid M; Awad MF; Omran A; Albalawi MA; Abdelaziz MA; Al Areefy A; Jafri I
Molecules; 2022 Oct; 27(20):. PubMed ID: 36296520
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
